Kips Bay Medical, Inc.: 10-Q filed 2012-08-09
What Kips Bay Medical, Inc. reported in its quarterly report filed 2012-08-09 (fiscal Q2 2012): 27 published measures, 68 facts as tagged in accession 0001104659-12-056575.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-09
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001104659-12-056575 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Kips Bay Medical, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 8,632,000 | USD | |
| At 2011-12-31 | 10,667,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 8,202,000 | USD | |
| At 2011-12-31 | 10,407,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 2,330,000 | USD | |
| At 2011-12-31 | 6,211,000 | USD | |
| At 2011-07-02 | 4,017,000 | USD | |
| At 2010-12-31 | 3,548,000 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 82,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | 42,000 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -26,997,000 | USD | |
| At 2011-12-31 | -24,343,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 478,000 | USD | |
| At 2011-12-31 | 467,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 312,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | 187,000 | USD | 183 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -1,387,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,663,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | -1,049,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | -1,963,000 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 8,154,000 | USD | |
| At 2011-12-31 | 10,200,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 430,000 | USD | |
| At 2011-12-31 | 260,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 168,000 | USD | |
| At 2011-12-31 | 85,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 31,000 | USD | |
| At 2011-12-31 | 40,000 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 982,000 | USD | |
| At 2011-12-31 | 892,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 32,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 61,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | 27,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | 100,000 | USD | 183 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 752,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,574,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | 689,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | 1,242,000 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 667,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,150,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | 387,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | 821,000 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 16,345,579 | shares | |
| At 2011-12-31 | 16,245,579 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | -1,000 | USD | |
| At 2011-12-31 | -3,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 346,000 | USD | |
| At 2011-12-31 | 303,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 260,000 | USD | |
| At 2011-12-31 | 171,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 276,000 | USD | |
| At 2011-12-31 | 100,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -1,382,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,652,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | -1,049,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | -1,959,000 | USD | 183 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -1,383,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,654,000 | USD | 182 |
| 2011-04-03 to 2011-07-02 | -1,044,000 | USD | 91 |
| 2011-01-01 to 2011-07-02 | -1,954,000 | USD | 183 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 53,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | 48,000 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -9,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | 6,000 | USD | 183 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 90,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | 141,000 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 83,000 | USD | 182 |
| 2011-01-01 to 2011-07-02 | -128,000 | USD | 183 |
Inspect the source
- Entity
- Kips Bay Medical, Inc. / CIK 0001460198
- Captured
- SEC response SHA-256
537fd91bdfed6723df188e5ded136a58ab17a2300edab415658493f14025eedb
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001460198.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))